Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 5, 2026

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

CD44 in hematological neoplasias.

Magdalena Katharina Hertweck1, Felix Erdfelder, Karl-Anton Kreuzer

  • 1Department I of Internal Medicine, University at Cologne, Kerpener Strasse 62, 50937, Cologne, Germany.

Annals of Hematology
|January 25, 2011
PubMed
Summary

The CD44 protein, a transmembrane glycoprotein, plays diverse roles in cell interactions and signaling. Altered CD44 expression in hematological cancers indicates poor prognosis and offers potential therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AML.

Antimicrobial agents and chemotherapy·2026
Same author

Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial.

Blood·2026
Same author

The landscape and evolution of clonal hematopoiesis in chronic lymphocytic leukemia.

Blood·2026
Same author

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.

The New England journal of medicine·2025
Same author

Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.

Leukemia·2025
Same author

Acalabrutinib treatment for older (aged ≥80 years) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial.

Blood·2025

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Immunology

Background:

  • CD44 is a heterogeneous transmembrane glycoprotein family involved in cell adhesion, signaling, and cytoskeleton linkage.
  • Its expression varies significantly with cell type, activation, and differentiation stage.

Purpose of the Study:

  • To explore the multifaceted roles of CD44 in normal hematopoiesis and its implications in hematological malignancies.
  • To evaluate CD44 as a prognostic marker and therapeutic target in blood cancers.

Main Methods:

  • Analysis of CD44 protein structure and function.
  • Investigation of CD44 expression patterns in various hematopoietic cells and malignancies.
  • Review of CD44's role in cancer development, progression, and treatment resistance.

Main Results:

  • CD44 mediates key processes in hematopoiesis, including progenitor cell interaction and T-cell regulation.
  • Altered CD44 expression is linked to increased invasiveness, apoptotic resistance, and poor prognosis in hematological neoplasms.
  • CD44 expression levels aid in distinguishing between different hematological cancer subtypes.

Conclusions:

  • CD44 is a critical regulator in hematopoiesis and a significant factor in hematological malignancies.
  • Targeting CD44 presents a promising therapeutic strategy for blood cancers, potentially overcoming treatment resistance.
  • CD44 serves as a valuable prognostic biomarker and diagnostic tool in hematological oncology.

More Related Videos

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

Related Experiment Videos

Last Updated: Jun 5, 2026

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016